KemPharm Announces Positive Topline Results from Intranasal Human Abuse Potential Trial of KP415 Prodrug
KemPharm, Inc. (KMPH)
Last kempharm, inc. earnings: 2/28 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.kempharm.com/investor-overview
Company Research
Source: GlobeNewswire
NDA Filing for KP415 Anticipated As Soon As First Quarter of 2019 Following Successful Completion of HAP Program d-MPH = d-methylphenidate hydrochloride. Drug Liking was assessed on a bipolar scale. (0 = Strong Disliking, 50 = Neutral, 100 = Strong Liking). Subjects received equimolar doses of SDX and d-MPH HCl Highlights of KP415.A02 Intranasal HAP Trial Results: Mean Drug Liking (Emax) of intranasal KP415 Prodrug (serdexmethylphenidate) was statistically significantly lower than d-methylphenidate hydrochloride CORALVILLE, Iowa, Sept. 17, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced topline results from its intranasal (IN) human abuse potential (HAP) clinical t
Show less
Read more
Impact Snapshot
Event Time:
KMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KMPH alerts
High impacting KemPharm, Inc. news events
Weekly update
A roundup of the hottest topics